5/21
6:30 pm - 9:30 pm
Licensing Executives Society CT Chapter. "Burning Intellectual Property Issues of 2008: Patent Reform and Why It Was Blocked in Court; Supreme Court Rulings of 2007 and Their Effects in 2008 and Beyond." President's Room, Woolsey Hall, Yale University, 500 College St., New Haven. more
5/22
1:00 pm - 3:00 pm
Biobanks: The Promise and Public Health Challenges of Biorepositories for Genomics Research. Presented by The CT Dept of Public Health Virtual Office of Genomics. Crowne Plaza, 100 Berlin Road, Cromwell. more
6/4
3:00 pm - 7:00 pm
Annual UConn Tech Transfer Event. Presentations and reception. Stamford UConn Campus, Stamford. more
6/4
7:00 pm - 8:30 pm
MIT Enterprise Forum of CT: "Innovation to Commercialization - Using Government Funds to Kick Start Your Start-Up." Stamford UConn Campus, Stamford. more
6/18
12 noon - 1:00 pm
Brown Bag Lunch. "Stem Cells: Everything You Wanted to Know But Were Afraid to Ask." Presented by the Yale Stem Cell Center. TAC Auditorium, N107, Yale University, New Haven more



Co-Chair
Peter R. Farina, Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

Co-Chair
David W. Keiser, president and chief operating officer, Alexion Pharmaceuticals, Inc.

President & CEO
Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Secretary
Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Treasurer
Michelle Bowman, partner, PricewaterhouseCoopers LLP


Executive Committee Members

Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Peter R. Farina, Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

David W. Keiser, president and chief operating officer, Alexion Pharmaceuticals, Inc.

Frank J. Marco, J.D., partner, Wiggin and Dana LLP

Harry H. Penner, Jr., president & CEO, Marinus Pharmaceuticals, Inc.

Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE


Board of Directors

Daniel D. Adams, president & CEO, Protein Sciences Corporation

Bruce D. Alexander, vice president & director of New Haven and state affairs, Yale University

Timothy F. Bannon, special counsel, Purdue Pharma L.P.

Heather J. Bessoff White, D.V.M., assistant secretary, Connecticut Veterinary Medical Association

Edward M. Bowman, Jr., chairman, Connecticut Innovations

Michelle Bowman, partner, PricewaterhouseCoopers LLP

Peter Farina, Ph.D., senior vice president, development, Boehringer Ingelheim Pharmaceuticals, Inc.

Susan Froshauer, Ph.D., president & CEO, Rib-X Pharmaceuticals, Inc.

Judith B. Greiman, president, Connecticut Conference of Independent Colleges

Michael J. Hogan, Ph.D. , president, University of Connecticut

David W. Keiser, president & chief operating officer, Alexion Pharmaceuticals, Inc.

Michael D. Kishbauch, president and CEO, Achillion Pharmaceuticals, Inc.

Hollis D. Kleinert, Ph.D., president, Kleinert Scientific/Commercial Consultations

Frank J. Marco, J.D., partner, Wiggin and Dana LLP

Christopher K. McLeod, president and CEO, 454 Life Sciences

Sandra S. Oliver, vice president of public policy & state government affairs, Bayer HealthCare

Harry H. Penner, Jr., president & CEO, Marinus Pharmaceuticals, Inc.

Paul R. Pescatello, J.D., Ph.D., president & CEO, CURE

Gordon P. Polley, chairman, The Institutes for Pharmaceutical Discovery, LLC

Kevin Rakin, president, Advanced BioHealing

John E. Rossi, senior vice president, emerging growth/technology, Webster Bank

Jonathan M. Rothberg, Ph.D., chairman of the board, 454 Life Sciences

Seth A. Rudnick, M.D., general partner, Canaan Partners

David I. Scheer, president, Scheer and Company

John S. Swen, vice president, science policy & public affairs, Pfizer, Inc.

James P. Torgerson , chairman, president & CEO, UIL Holdings Corporation

Designed by BlausenLisi
Copyright © 2006 Connecticut United for Research Excellence, Inc.